Quorex Pharmaceuticals Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Quorex Pharmaceuticals General Information

Description

Developer of new classes of broad-spectrum anti-infective drugs intended to disable disease-causing mechanisms in pathogenic bacteria. The company's drugs exert a therapeutic effect by rapidly shutting down the production of virulence factors and disables a pathogen to survive by destroying its ability to communicate, obtain nutrients and fight with the host's immune system, providing medical practitioners with a new class of drug that inactivates a broad range of pathogens including those that resist conventional antibiotics.

Contact Information

Website
www.quorex.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1890 Rutherford Road
  • Suite 200
  • Carlsbad, CA 92008
  • United States
+1 (760)
Primary Industry
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 1890 Rutherford Road
  • Suite 200
  • Carlsbad, CA 92008
  • United States
+1 (760)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quorex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 01-Jan-2005 Completed Out of Business
5. Out of Business 01-Dec-2004 Completed Out of Business
4. Early Stage VC 08-Nov-2004 Completed Product Development
3. Early Stage VC (Series B) 04-Oct-2002 Completed Startup
2. Early Stage VC 27-Feb-2001 $18.5M $18.5M Completed Product Development
1. Early Stage VC Completed Startup
To view Quorex Pharmaceuticals’s complete valuation and funding history, request access »

Quorex Pharmaceuticals Patents

Quorex Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2537860-A1 Gyrase inhibitors Inactive 05-Sep-2003
WO-2005026162-A1 Gyrase inhibitors Inactive 05-Sep-2003
AU-2002365928-A1 Inhibitors of autoinducer transporters Inactive 26-Oct-2001
WO-2003064592-A2 Inhibitors of autoinducer transporters Inactive 26-Oct-2001
WO-2003064592-A3 Inhibitors of autoinducer transporters Inactive 26-Oct-2001 C07K14/255
To view Quorex Pharmaceuticals’s complete patent history, request access »

Quorex Pharmaceuticals Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDIB BioScience Venture Management Venture Capital Minority
IngleWood Ventures Venture Capital Minority
Johnson & Johnson JJDC Corporate Venture Capital Minority
Pacific Growth Equities Investment Bank Minority
Prism Venture Management Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Quorex Pharmaceuticals FAQs

  • When was Quorex Pharmaceuticals founded?

    Quorex Pharmaceuticals was founded in 1999.

  • Where is Quorex Pharmaceuticals headquartered?

    Quorex Pharmaceuticals is headquartered in Carlsbad, CA.

  • What industry is Quorex Pharmaceuticals in?

    Quorex Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Quorex Pharmaceuticals a private or public company?

    Quorex Pharmaceuticals is a Private company.

  • What is Quorex Pharmaceuticals’s current revenue?

    The current revenue for Quorex Pharmaceuticals is .

  • How much funding has Quorex Pharmaceuticals raised over time?

    Quorex Pharmaceuticals has raised $34.3M.

  • Who are Quorex Pharmaceuticals’s investors?

    CDIB BioScience Venture Management, IngleWood Ventures, Johnson & Johnson JJDC, Pacific Growth Equities, and Prism Venture Management are 5 of 6 investors who have invested in Quorex Pharmaceuticals.

  • When was Quorex Pharmaceuticals acquired?

    Quorex Pharmaceuticals was acquired on 01-Jan-2005.

  • Who acquired Quorex Pharmaceuticals?

    Quorex Pharmaceuticals was acquired by Pfizer.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process